{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:57Z","timestamp":1791348597260,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104508","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:38:33Z","timestamp":1789882713000},"page":"104508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of anion excipients on the viscosity of high-concentration mAb solution"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3606-1662","authenticated-orcid":false,"given":"Souhei","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-9334","authenticated-orcid":false,"given":"Risa","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8269-7803","authenticated-orcid":false,"given":"Tetsuo","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5181-179X","authenticated-orcid":false,"given":"Susumu","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104508_bib0001","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2443538","article-title":"Antibodies to watch in 2025","volume":"17","author":"Crescioli","year":"2025","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.xphs.2026.104508_bib0002","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.xphs.2021.11.008","article-title":"Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: Quo vadis?","volume":"111","author":"Jiskoot","year":"2022","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104508_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103877","article-title":"Current and emerging strategies for subcutaneous delivery of high concentration and high-dose antibody therapeutics","volume":"114","author":"Ren","year":"2025","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cpt.3150","article-title":"Subcutaneous administration of monoclonal antibodies: pharmacology, delivery, immunogenicity, and learnings from applications to clinical development","volume":"115","author":"Davis","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104508_bib0005","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.xphs.2026.104508_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ddtec.2020.08.005","article-title":"Development challenges of high concentration monoclonal antibody formulations","volume":"37","author":"Koll\u00e1r","year":"2020","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104508_bib0007","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2211185","article-title":"High concentration formulation developability approaches and considerations","volume":"15","author":"Zarzar","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.xphs.2026.104508_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.hfh.2025.100091","article-title":"Engineered testbeds for investigating syringe injection performance in human factors studies","volume":"7","author":"Pack","year":"2025","journal-title":"Human Factors Healthcare"},{"issue":"8","key":"10.1016\/j.xphs.2026.104508_bib0009","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/1389203719666171213114919","article-title":"Viscosity control of protein solution by small solutes: a review","volume":"19","author":"Hong","year":"2018","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jps.22831","article-title":"Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects","volume":"101","author":"Yadav","year":"2012","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104508_bib0011","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11095-012-0965-4","article-title":"Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities","volume":"30","author":"Saito","year":"2013","journal-title":"Pharm Res"},{"issue":"33","key":"10.1016\/j.xphs.2026.104508_bib0012","doi-asserted-by":"crossref","first-page":"10375","DOI":"10.1021\/acs.jpcb.5b02459","article-title":"Hofmeister effects in monoclonal antibody solution interactions","volume":"119","author":"Arzen\u0161ek","year":"2015","journal-title":"J Phys Chem B"},{"issue":"19","key":"10.1016\/j.xphs.2026.104508_bib0013","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1021\/bi400232p","article-title":"Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody","volume":"52","author":"Majumdar","year":"2013","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0014","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/bit.22983","article-title":"Hydrophobic salts markedly diminish viscosity of concentrated Protein Solutions","volume":"108","author":"Du","year":"2011","journal-title":"Biotechnol Bioeng"},{"issue":"36","key":"10.1016\/j.xphs.2026.104508_bib0015","doi-asserted-by":"crossref","first-page":"15249","DOI":"10.1073\/pnas.0907616106","article-title":"The inverse and direct Hofmeister series for lysozyme","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xphs.2026.104508_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124472","article-title":"Histidine as a versatile excipient in the protein-based biopharmaceutical formulations","volume":"662","author":"Lv","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104508_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2016.11.027","article-title":"Small-scale screening method for low-viscosity antibody solutions using small-angle X-ray scattering","volume":"112","author":"Fukuda","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0018","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10047-013-0707-3","article-title":"Blood viscometer applying electromagnetically spinning method","volume":"16","author":"Fukunaga","year":"2013","journal-title":"J Artif Organs"},{"key":"10.1016\/j.xphs.2026.104508_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114221","article-title":"Advancing injection force modeling and viscosity-dependent injectability evaluation for prefilled syringes","volume":"197","author":"Wu","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104508_bib0020","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/jps.23647","article-title":"High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies","volume":"102","author":"Zarraga","year":"2013","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104508_bib0021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/19420862.2017.1358328","article-title":"Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies","volume":"9","author":"Sudrik","year":"2017","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0022","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/acs.molpharmaceut.3c00963","article-title":"Unraveling the microscopic mechanism of molecular ion interaction with monoclonal antibodies: impact on protein aggregation","volume":"21","author":"Saurabh","year":"2024","journal-title":"Mol Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2026.104508_bib0023","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s11095-013-1221-2","article-title":"Thermodynamic and fluorescence analyses to determine mechanisms of IgG1 stabilization and destabilization by arginine","volume":"31","author":"Fukuda","year":"2014","journal-title":"Pharm Res"},{"issue":"52","key":"10.1016\/j.xphs.2026.104508_bib0024","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1073\/pnas.1421779112","article-title":"In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability","volume":"111","author":"Sharma","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.xphs.2026.104508_bib0025","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.1810576116","article-title":"Five computational developability guidelines for therapeutic antibody profiling","volume":"116","author":"Raybould","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0026","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/19420862.2017.1285479","article-title":"In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions","volume":"9","author":"Tomar","year":"2017","journal-title":"MAbs"},{"issue":"9","key":"10.1016\/j.xphs.2026.104508_bib0027","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1248\/bpb.b22-00263","article-title":"Estimation of the viscosity of an antibody solution from the diffusion interaction parameter","volume":"45","author":"Shimomura","year":"2022","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"10.1016\/j.xphs.2026.104508_bib0028","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1021\/acs.molpharmaceut.3c00797","article-title":"Improved diffusion interaction parameter measurement to predict the viscosity of concentrated mAb solutions","volume":"20","author":"Wei","year":"2023","journal-title":"Mol Pharmaceutics"},{"issue":"3","key":"10.1016\/j.xphs.2026.104508_bib0029","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/jps.21898","article-title":"Specific interactions in high concentration antibody solutions resulting in high viscosity","volume":"99","author":"Yadav","year":"2010","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104508_bib0030","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/mp5002334","article-title":"The role of electrostatics in protein-protein interactions of a monoclonal antibody","volume":"11","author":"Roberts","year":"2014","journal-title":"Mol Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104508_bib0031","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.xphs.2019.10.038","article-title":"Relation of colloidal and conformational stabilities to aggregate formation in a monoclonal antibody","volume":"109","author":"Oyama","year":"2020","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104508_bib0032","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jps.24105","article-title":"Role of benzyl alcohol in the unfolding and aggregation of interferon \u03b1-2A","volume":"104","author":"Bis","year":"2015","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104508_bib0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/abt\/tbad022","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antibody Ther"},{"issue":"4","key":"10.1016\/j.xphs.2026.104508_bib0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/abt\/tbab027","article-title":"US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives","volume":"4","author":"Wang","year":"2021","journal-title":"Antibody Ther"},{"issue":"22","key":"10.1016\/j.xphs.2026.104508_bib0035","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1021\/jp111920y","article-title":"Arginine and the Hofmeister series: the role of ion-ion interactions in protein aggregation suppression. Arginine and the Hofmeister series","volume":"115","author":"Schneider","year":"2011","journal-title":"J Phys Chem B"},{"issue":"10","key":"10.1016\/j.xphs.2026.104508_bib0036","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1021\/acs.molpharmaceut.6b00255","article-title":"Influence of arginine salts on the thermal stability and aggregation kinetics of monoclonal antibody: dominant role of anions","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Pharmaceutics"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:53:44Z","timestamp":1791345224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003588"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104508","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of anion excipients on the viscosity of high-concentration mAb solution","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104508"}}